Rowland Thomas, Gopal Robin, Patel Monika, Celma Cristina, Campbell Colin Nj, Machin Nicholas, Taylor Scott, Graham Shauni-Lea, Harris Kathryn, Pereira Spiro, Saliba Vanessa, Zambon Maria
Virus Reference Division, UK Health Security Agency, London, United Kingdom.
Clinical Academic Graduate School, University of Oxford, Oxford, United Kingdom.
Euro Surveill. 2025 Apr;30(16). doi: 10.2807/1560-7917.ES.2025.30.16.2500025.
BackgroundVaccine-derived polioviruses (VDPVs) continue to circulate internationally, causing sporadic cases and outbreaks of paralytic polio in countries certified as polio-free. In 2022, sustained detection of type 2 VDPVs was reported in environmental surveillance samples collected from London. Genetic mutations indicative of loss of attenuation of virulence were observed, consistent with community transmission events over several months.AimWe aimed to determine the extent of geographical spread of transmission in an area of environmental poliovirus detection.MethodsWe implemented an opportunistic, cross-sectional survey in areas where environmental surveillance indicated sustained VDPV transmission between October 2022 and April 2023. Residual stool samples taken from children < 16 years presenting to primary or secondary healthcare were examined for enteroviruses, including poliovirus. Methods for poliovirus detection recommended by the World Health Organization, including virus isolation in cell culture, PCR and molecular characterisation, were applied to residual stool material on a daily basis with real-time clinical reporting.ResultsWe examined 1,251 stool samples from 1,051 children presenting to healthcare with illness over a 6-month period. A range of enteroviruses from groups A, B and C were found, but no poliovirus was detected. Documented polio vaccination coverage was high, between 95% and 98% in under 5-year-olds.ConclusionPoliovirus was not widespread in the area of environmental poliovirus isolation. Opportunistic poliovirus testing of residual stool samples taken from children seeking healthcare was feasible and can be implemented rapidly in areas where poliovirus circulation is suspected, although untargeted sampling may not adequately capture populations at highest risk.
背景
疫苗衍生脊髓灰质炎病毒(VDPV)继续在国际上传播,在已认证无脊髓灰质炎的国家引发散发病例和麻痹性脊髓灰质炎疫情。2022年,在从伦敦采集的环境监测样本中报告持续检测到2型VDPV。观察到表明毒力减弱丧失的基因突变,这与数月来的社区传播事件一致。
目的
我们旨在确定环境脊髓灰质炎病毒检测区域内传播的地理扩散程度。
方法
我们于2022年10月至2023年4月在环境监测表明存在持续VDPV传播的地区开展了一项机会性横断面调查。对到初级或二级医疗机构就诊的16岁以下儿童的残留粪便样本进行肠道病毒检测,包括脊髓灰质炎病毒。每天将世界卫生组织推荐的脊髓灰质炎病毒检测方法,包括细胞培养中的病毒分离、PCR和分子特征分析,应用于残留粪便样本,并进行实时临床报告。
结果
在6个月期间,我们检查了1051名因病到医疗机构就诊的儿童的1251份粪便样本。发现了A、B和C组的一系列肠道病毒,但未检测到脊髓灰质炎病毒。有记录的脊髓灰质炎疫苗接种覆盖率很高,5岁以下儿童的接种率在95%至98%之间。
结论
脊髓灰质炎病毒在环境脊髓灰质炎病毒分离区域内并不广泛传播。对到医疗机构就诊儿童的残留粪便样本进行机会性脊髓灰质炎病毒检测是可行的,并且在怀疑有脊髓灰质炎病毒传播的地区可以迅速实施,尽管非针对性抽样可能无法充分覆盖风险最高的人群。